Newton, Ma., March 1, 2017 – Be the Partner®, provider of a strategic patient engagement platform to help sponsors stay connected with their trial patient community beyond the trial, has joined leading provider of technology-enabled clinical trial solutions Bioclinica’s eHealth App xChange. The partnership provides clinical researchers and sponsors expanded choices in patient-centric applications they can leverage as part of Bioclinica’s extensive and growing eHealth platform. Bioclinica’s App xChange creates an environment for collaboration among technology providers, and allows sponsors to leverage the value of integration within Bioclinica’s secure, validated eHealth Cloud™.
“We are proud that Bioclinica has chosen Be the Partner to be one of the offerings in its eHealth App xChange, and look forward to doing great things together,” said Thomas Klein, founder and CEO of Be the Partner.
With a blend of patient database and community and relationship management, Be the Partner helps patients stay engaged in clinical trials from pre-screening to their last visit and beyond, helping forge relationships with trial alumni that endure, creating opportunities for involvement in future studies.
“Patient engagement is very important and we look forward to exploring new ways to provide Bioclinica customers added value via our new App xChange member, Be the Partner,” said Bioclinica’s Vice President of Technology Alliances, eHealth Solutions Anne Zielinski.
About Be the Partner
Be the Partner is an exclusive SaaS platform providing a means for engaging actual trial participants, post-trial participants (trial alumni) and future trial participants, designers and patient advocates. while maintaining required patient anonymity. Be the Partner adds value to the actual services of biopharmaceutical companies, their vendors, sites and investigators that work inside clinical trials while bringing new and unique services outside the trial.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized by three business segments to deliver focused service supporting multifaceted technologies. The Medical Imaging and Biomarkers segment provides medical imaging and cardiac safety services and includes a molecular marker laboratory. The eHealth Solutions segment comprises the eClinical Solutions platform; Financial Lifecycle Solutions; Safety and Regulatory Solutions; Strategic Consulting Services; App xChange Alliances; and eHealth Cloud Services. Under the Global Clinical Research segment, Bioclinica offers a network of research sites, patient recruitment services, and a post-approval research division. The Company serves more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 – through a network of offices in the U.S., Europe and Asia. Learn more at www.Bioclinica.com. See Bioclinica's news releases here.